Normally, two standalone procedures are needed to treat both fat and muscle, but now with EMSCULPT NEO this single solution simultaneously melts fat while building muscles. As such, it is a faster, more economical and more efficacious solution than combining multiple procedures. EMSCULPT NEO is a versatile solution that provides inclusivity to most body types; patients up to a BMI of 35 can successfully experience this treatment and its results. 

"There are a great number of benefits that customers will reap after using EMSCULPT NEO. This is a result of us combining the technologies of radio frequency heating to burn fat, and high-intensity focused electromagnetic waves to build muscle," said Ron Borsheim, VP of Product Development of BTL. "Heating the muscles while burning fat allows for synergistic effects that result in more fat reduction and muscle growth than any single gold standard procedure. We are thrilled about the results of seven new clinical studies that show an average of 30% fat reduction and/or 25% increase in muscle mass."

For best results, four treatments are recommended over the course of four weeks.

"While clients are visiting offices for treatments, we are still living in uncertain times, so we know that treatments need to be quick, efficient and worth their time," said John Ferris, VP of US Marketing, of BTL. "EMSCULPT NEO ensures that the client's expectations are exceeded with the results, due to its 2-in-1 solution of burning fat and building muscle at once."

David J. Goldberg, MD, JD shared a similar sentiment when he stated, "It is less time consuming and offers more bang for the buck—with better results. This is the next dimension in body contouring."

"There was a rapid, very measurable, noticeable reduction in fat with an increase in the muscle thickness, and these changes are much better than what we would get alone," shared Carolyn Jacob, MD.

For more information on EMSCULPT NEO and to find a physician near you, please visit www.bodybybtl.com. 

About BTL
Founded in 1993, BTL has grown to become one of the world's major manufacturers of medical and aesthetic equipment. With 1,900 employees located in more than 58 countries, BTL has revolutionized the way to offer the most advanced non-invasive solutions for body shaping, skin tightening & other medical aesthetic treatments, including women's intimate health and wellness. BTL's brands include EMSCULPT, EMSELLA, EMTONE, BTL Vanquish ME, BTL Exilis ULTRA, and BTL Cellutone. Additional information can be found at www.bodybybtl.com.

As of September 2020, BTL's European manufacturing facilities have been producing ventilators and masks.  Most recently, FFP2 (European Equivalent to N-95) flat-fit respirator masks, for both medical professionals and consumers. The respirator masks received both an FDA Emergency Use Authorization and a CE Marking.

"There is little doubt that this pandemic has changed the way we all do business.  BTL recognized that as a company, we needed to find a way to help our physicians and partners in the industry.  As a true manufacturer of aesthetic technologies, BTL was able to quickly re-prioritize some of its manufacturing efforts to start building ventilators, respirators and masks to provide support and protection for those who need it most," said Ron Borsheim, VP of Product Development.

"All staff and docs gave these masks a 5-star rating for comfort, breathability, tight seal and ear relief.  Ready to order many more," shared Robert Weiss, MD.

Melanie Palm, MD, FACS stated "I got to tell you, it's a real nice edge up in terms of comfort compared to some of the K95 and N95 respirators. Carolyn Jacob, MD further elaborated "They are more comfortable than any other mask we have been wearing."

More than 1 million masks are currently available for sale at its Massachusetts facility. To inquire or purchase the BTL FFP2 flat-fit healthcare respirator masks please visit: www.bodybybtl.com/masks.

About BTL
Founded in 1993, BTL has grown to become one of the world's major manufacturers of medical and aesthetic equipment. With 1,800 employees located in more than 55 countries, BTL has revolutionized the way to offer the most advanced non-invasive solutions for body shaping, skin tightening & other medical aesthetic treatments, including women's intimate health and wellness. BTL's brands include EMSCULPT, EMSELLA, EMTONE, BTL Vanquish ME, BTL Exilis ULTRA, and BTL Cellutone. Additional information can be found at www.bodybybtl.com.

BTL Industries, Inc. ("BTL"), the leading manufacturer of the EMSCULPT body-contouring device and other products for non-invasive body-shaping procedures, filed a complaint today with the United States International Trade Commission ("ITC"), asking the Commission to prevent Allergan Limited, Allergan, Inc., Allergan USA Inc., Zeltiq Aesthetics, Inc., Zeltiq Ireland Unlimited Company ("Allergan"), and Zimmer MedizinSysteme GmbH, Germany ("Zimmer") from importing products that infringe BTL's patents into the United States. BTL concurrently filed a lawsuit with the U.S. Federal District Court in the District of Delaware against Allergan and Zimmer on the same matter.

BTL, the manufacturer behind the revolutionary EMSCULPT technology, is continuing to set-the-pace in aesthetics and non-invasive body shaping and contouring. Today, the brand announced the launch of the new EMSELLA applicator with up to 2.5 Tesla (T) to treat all forms of male and female urinary incontinence. Building upon the existing clearances for the abdomen, buttocks, thighs, arms and calves, the new EMSELLA applicator makes EMSCULPT the first system to treat the whole core; and provide patients with a holistic solution to strengthening their pelvic floor.

“Since launching EMSCULPT in 2018, we’ve seen growing demand from physicians and patients to combine our two innovative and beloved treatments for a complete solution for the whole core,” shared John Ferris, VP of US Marketing, of BTL. “Patients coming for muscle toning are often ideal candidates for pelvic floor treatment.”

The EMSELLA applicator is specially designed to restore neuromuscular control and rehabilitation of weak pelvic muscles. “A 2007 study in The Journal of Women’s Health Physical Therapy concluded over 65% of women who suffer from abdominal separation have a pelvic floor disorder, so we know that there was a need to provide a solution for the whole core,” shared Carolyn Delucia, M.D.

“We can safely infer that using EMSCULPT to treat abdominal separation will complement the EMSELLA treatment. What this all means is that we can take a full-scale surgical mommy makeover, which costs a lot and involve a fair amount of risk, and reduce much of it to two non-invasive treatments that will be much less risky and much less expensive,” said Dr. Delucia. “In addition, the patients who underwent Core to Floor therapy, showed a significant increase in quality of life and often reverted back to activities, like exercising, that that they had forgone prior to treatment.”

For the best results, four 28-minute non-invasive treatments over the course of two weeks are recommended. The EMSCULPT platform delivers the highest amount energy in the treatment area resulting in the strongest muscle contractions induced by non-invasive device on the market.³ For more information on all EMSCULPT applicators and to find a physician near you, please visit www.bodybybtl.com. 

About BTL

Founded in 1993, BTL has grown to become one of the world’s major manufacturers of medical and aesthetic equipment. With 1,800 employees located in more than 55 countries, BTL has revolutionized the way to offer the most advanced non-invasive solutions for body shaping, skin tightening & other medical aesthetic treatments, including women’s intimate health and wellness. BTL’s brands include EMSCULPT, EMSELLA, EMTONE, BTL Vanquish ME, BTL Exilis ULTRA, and BTL Cellutone. Additional information can be found at www.bodybybtl.com.

1. Measured at the coil surface, data on file.
2. https://sciencenordic.com/researcher-zone-sweden/incontinence-affects-more-than-200-million-people-worldwide-so-why-isnt-more-being-done-to-find-a-cure/1454073
3. Average induced current for abdomen, buttocks and leg therapies, data on file.

BTL Industries, Inc. ("BTL") today announced it has filed a lawsuit against Allergan plc, Allergan USA, Inc., Allergan, Inc., and Zeltiq Aesthetics, Inc. The lawsuit alleges a wide-ranging false and misleading advertising campaign launched by Allergan relating to BTL's industry-leading EMSCULPT device for non-invasive muscle toning and body shaping.

According to the lawsuit, Allergan's marketing, sales materials, and social media advertising feature numerous deceptive comparisons of Allergan's CoolTone product to the EMSCULPT, and misrepresent Allergan's product as having performance advantages compared to EMSCULPT. 

"While BTL welcomes fair competition and competitive advertising, it was the egregious and misleading nature of their marketing that compelled us to file this lawsuit," said Filip Donner, Director of BTL Industries. "Long before bringing their product to the market, Allergan knowingly made false, deceptive, and misleading descriptions of fact concerning the nature, characteristics, and qualities of the EMSCULPT device as compared to their product."

In particular, Allergan's comparisons about magnetic intensity are false on their face. The tests presented in the lawsuit show that Allergan's product and BTL's EMSCULPT have on average substantially equivalent magnetic intensity at the point of patient contact. Further, Allergan's statements about magnetic intensity are misleading when they falsely imply that magnetic intensity is a measure of power, or efficacy.

"Alone, magnetic intensity is not an accurate measure of the amount of induced electrical current delivered to the tissue by the magnetic field during therapy. The higher the induced electrical current, the stronger the muscle contraction," explained Ron Borsheim, VP – Business Development.

Testing presented in the lawsuit shows that BTL's EMSCULPT device, when averaging abdomen, buttocks and leg therapies, induces up to 56% more electrical current into the target tissue than Allergan's product.

"We owe it to our customers and employees to hold Allergan accountable for attempting to gain an unfair competitive advantage through these misleading practices," added Ron Borsheim.

This lawsuit, filed in the US District Court for the District of Delaware, is the latest filing with the same court against Allergan. The previous lawsuit asserts that the Cooltone device, manufactured by Zimmer for Allergan, infringes on BTL's United States patents. Today's lawsuit seeks a court order halting Allergan's false and misleading advertising, and requests corrective marketing and advertising, damages, and attorneys' fees.

About Emsculpt:

EMSCULPT uses high intensity focused electromagnetic energy technology (HIFEM®) to induce powerful muscle contractions not achievable through voluntary contractions. BTL's proprietary protocols create supramaximal muscle contractions that force muscle tissue to adapt to such extreme conditions. The EMSCULPT went through many years of research and development before launching in the United States in 2018. BTL was the first to apply its patented high intensity focused electromagnetic energy technology to aesthetics, and since then Emsculpt has received numerous awards and industry recognition. For more details, go to www.emsculpt.com.

BTL Aesthetics (“BTL”), a leading manufacturer of non-invasive technologies for body shaping, announced today that its US affiliate has filed a lawsuit against Allergan plc, Ireland and its affiliates, and Zimmer MedizinSysteme GmbH, Germany, and its affiliate, in the U.S. Federal District Court for the District of Delaware. 

The lawsuit asserts that the Cooltone device, manufactured by Zimmer for Allergan, infringes on BTL’s United States patents. The lawsuit further asserts that Allergan’s Coolsculpting, when used before, or after the Cooltone therapy, infringes on BTL’s United States patent for the therapeutic application of the two technologies. 

BTL’s Emsculpt has been a clear innovation leader in the muscle category, revolutionizing the non-invasive body shaping market. Utilizing proprietary HIFEM technology, Emsculpt introduced an entirely new category of muscle strengthening technology to aesthetics that goes beyond waist line reduction and the elimination of fat cells. 

“The intellectual property behind Emsculpt was developed both for and with the aesthetic physician community in mind,” said Filip Donner, Director of BTL. “We shall vigorously defend our intellectual property to protect the substantial investments our customers have made, and to preserve the leadership position we have developed over many years of effort. This lawsuit is the first domino to fall as we enforce our patents and other intellectual property rights in the United States and in other jurisdictions.“ 

BTL is seeking an injunction and monetary damages. The lawsuit is intended to prevent Allergan from importing and selling Cooltone systems in the United States, and to prevent Allergan from marketing Cooltone alone or in conjunction with their Coolsculpting therapy. 

About BTL Group

Founded in 1993, BTL Group has grown to become one of the major manufacturers of medical and aesthetic equipment. With over 2,000 employees located in more than 53 countries, BTL has revolutionized the way to offer the most advanced non-invasive solutions for body shaping, skin tightening & other medical aesthetic treatments, including treatment of incontinence. BTL's brands include EMSCULPT, EMSELLA and EMTONE. For more information, visit bodybybtl.com.

BTL, HIFEM and EMSCULPT are registered trademarks of BTL or its affiliates in the U.S. and other countries. Other names may be trademarks or registered trademarks of their respective owners.

BTL, the manufacturer behind the game changing EMSCULPT treatment, further transforms existing aesthetic protocols with its latest technology—EMTONE. Unveiled today, EMTONE raises the bar in the treatment of cellulite by being the first treatment to apply radio frequency and targeted pressure energy simultaneously. This innovative combination allows the treatment to address all major contributing factors to cellulite, making it the first and only effective solution for cellulite without any downtime.

“BTL is dedicated to ongoing research and innovation in order to continually bring new, effective solutions to our physician partners and patients,” shared John Ferris, VP of Marketing for BTL. “With the launch of EMSCULPT last year, we shifted the body shaping paradigm entirely as the first to address muscle tone and definition. With the introduction of EMTONE, we’re excited to do the same for the treatment of cellulite, further solidifying the brand’s leadership position within the industry.”

The first of its kind energy combination—thermal monopolar radio frequency and mechanical targeted pressure energy— is what sets EMTONE apart from similar treatments available. This unrivaled combination has a profound effect on connective tissues that lead to cellulite, resulting in increased production of collagen and elastin to effectively address all major contributing factors to cellulite and smooth the appearance of dimpling. EMTONE can also be used on all body types with no BMI or skin color restrictions.

“Approximately 90% of women have some form of cellulite, and it’s something that numerous patients bring up to me on a daily basis,” shared Dr. Dendy Engelman, board certified dermatologist. “Up until now the treatment of cellulite has been extremely challenging as there hasn’t been an effective solution, or one without downtime. I’m thrilled to now have EMTONE to offer as it fills the existing void in cellulite treatments.”

Clinical studies demonstrate that EMTONE is 64% more effective than standalone cellulite treatments for building elastin, and 59% more effective for building collagen. Additionally, EMTONE was shown to be 50% faster than standalone therapies, with a 90% rate of patient satisfaction.

“EMTONE sets an entirely new standard for the treatment of cellulite,” says Dr. Paul Jarrad Frank, Celebrity Cosmetic Dermatologist and Founder of PFRANKMD & Skin Salon. “There has never been a non-invasive cellulite treatment that has shown such high levels of patient satisfaction within the industry. Not only do patients experience better results but they also see results faster than existing protocols.” added Dr. Frank.

For best results, most patients undergo 4 treatments, scheduled once or twice a week. A treatment typically takes about 20 minutes depending on the treated area. For more information on EMTONE and to find a physician near you, please visit www.bodybybtl.com.

About BTL Founded in 1993, BTL has grown to become one of the world’s major manufacturers of medical and aesthetic equipment. With over 1,500 employees located in more than 53 countries, BTL has revolutionized the way to offer the most advanced non-invasive solutions for body shaping, skin tightening & other medical aesthetic treatments, including women’s intimate health and wellness. BTL’s brands include EMSCULPT, BTL EMSELLA, EMTONE, BTL Vanquish ME, BTL Exilis ULTRA, and BTL Cellutone. Additional information can be found at www.bodybybtl.com.

BTL, the manufacturer behind the game-changing EMSCULPT technology, is continuing to raise the bar in aesthetics and non-invasive body shaping. Today, the brand announced its latest FDA clearance for EMSCULPT, which is now FDA cleared to strengthen, firm and tone the arms and calves with the newly unveiled Small Contour Applicators. Building upon the existing clearances for the abdomen, buttocks, and thighs, the new Small Contour Applicator brings the unrivaled EMSCULPT results to even more key muscle groups, making it the ONLY non-invasive treatment that is FDA cleared to tone and strengthen the arms and calves as well.

"Since launching EMSCULPT last year, we've seen growing demand from physicians and patients to bring the technology to other tough to target areas of the body," shared John Ferris, VP of US Marketing, of BTL. "Given our unique HIFEM procedures, we knew 'one applicator would not fit all' so we're excited to unveil the Small Contour Applicator in order to deliver targeted treatment for smaller muscle groups including the arms and calves."

The Small Contour Applicator is specially designed to target these smaller muscle groups via a unique, ergonomic design and adjusted energy field. "The amount of research that went into the development of the new applicator is apparent by the specificity used to address the unique needs of these muscle groups," shared Dr. Minni Saluja, Cosmetic Surgeon who conducted clinical trials for the brand. "The halfpipe design in combination with the higher energy field –which delivers a higher energy per cm –allows us to directly target these smaller areas while preventing the energy from stimulating antagonist muscles for improved outcomes and patient comfort."

"We conducted extensive trials with the Small Contour Applicator and utilized ultrasound and MRI technology to demonstrate its effectiveness for treating these new areas of the body," shared Dr. Bruce Katz, Director of the JUVA Skin & Laser Center in NY and Clinical Professor at the Icahn School of Medicine at Mt Sinai Hospital, who conducted clinical trials for the brand. "We found the bicep and tricep muscles showed an increase in muscle mass two weeks following the fourth treatment, as well as an overall fat reduction in the arms. The treatment also increased volumetric muscle mass in the calves. These findings are particularly noteworthy as up until now there hasn't been an effective non-invasive solution to address these areas of the body," added Dr. Katz.

Four 20-minute treatments, over the course of two weeks, represent the shortest procedure currently available for the non-invasive muscle strengthening. The new Small Contour Applicator and the EMSCULPT Large Applicator possess the highest intensity delivering the highest amount energy in the treatment area. For more information EMSCULPT and to find a physician near you, please visit www.bodybybtl.com.

About BTL
Founded in 1993, BTL has grown to become one of the world's major manufacturers of medical and aesthetic equipment. With over 1,500 employees located in more than 53 countries, BTL has revolutionized the way to offer the most advanced non-invasive solutions for body shaping, skin tightening & other medical aesthetic treatments, including women's intimate health and wellness. BTL's brands include EMSCULPT, BTL EMSELLA, BTL Vanquish ME, BTL Exilis ULTRA, and BTL Cellutone. Additional information can be found at www.bodybybtl.com.

BTL, leaders in non-invasive aesthetics, today announced a partnership with Dress for Success – a global not-forprofit organization that empowers women to achieve economic independence by providing a network of support, professional attire and development tools so that they can thrive in work and in life. This partnership kicks-off a broader marketing effort by BTL – BTL Cares -- which celebrates BTL as #TheCompanyWithAConscious and provides a platform to engage physician partners by creating an opportunity for them to give back to their local communities. Through the partnership with Dress for Success, participating practices will be hosting "accessory drives" in-office that directly support the local Dress for Success chapter.

"BTL is committed to empowering individuals to feel their best, which is why we're excited to partner with an organization like Dress for Success," shared John Ferris, VP of US Marketing, of BTL. "As a company, we recognize that our partners and the patients themselves are the secret to our success. Through our BTL Cares program, we look forward to giving back to the local communities where our partners and patients reside."

Through BTL Cares, the brand is supporting Dress for Success on both the national and regional levels. BTL will empower HCP partners within ten key markets to host accessory drives. Participating practices will collect accessories at their practice, including handbags, totes, jewelry, belts and scarves. Beyond that, BTL will be supporting Dress for Success via a monetary donation, helping the organization continue to offer their wide range of programs in support of women striving for economic independence.

BTL Cares is a brand initiative which will evolve and grow with partnerships that have a similar mission and focus on individual and collective empowerment. Through the program, the brand will also look to participate in various events on the regional level, giving employees, physicians and patients the opportunity to give back to their community on an ongoing basis.

"I was personally blessed with BTL's support when Hurricane Hervey hit the Houston area," shared Dr. Suneel Chilukuri, Board Certified Cosmetic & Dermatologic Surgeon based in Houston, TX. "Not only did numerous BTL employees offer to help with our immediate clean up, BTL provided a substantial monetary donation to help the Houston community rebuild. Every company has the power to contribute, but BTL chooses to contribute. This is one more reason why I continue to partner with BTL," added Dr. Chilukuri.

For more information on BTL and their portfolio of treatments – including EMSCULPT, which revolutionized the aesthetics industry with its launch last year as the first and only treatment to strengthen muscle and sculpt the body – and to find a physician near you, please visit www.bodybybtl.com.

About BTL
Founded in 1993, BTL has grown to become one of the world's major manufacturers of medical and aesthetic equipment. With over 1,500 employees located in more than 53 countries, BTL has revolutionized the way to offer the most advanced non-invasive solutions for body shaping, skin tightening & other medical aesthetic treatments, including women's intimate health and wellness. BTL's brands include EMSCULPT, BTL EMSELLA, BTL Vanquish ME, BTL Exilis ULTRA, and BTL Cellutone. Additional information can be found at www.bodybybtl.com.

About Dress for Success
Dress for Success is a global not-for-profit organization that empowers women to achieve economic independence. Since 1997, Dress for Success has expanded to more than 160 cities in 30 countries and has helped over 1,000,000 women achieve economic independence. To learn more about Dress for Success, visit https://dressforsuccess.org

BTL, leaders in non-invasive aesthetics, today announced a partnership with actress and lifestyle mogul, Drew Barrymore, to promote EMSCULPT® – the first and only non-invasive treatment to go beyond the elimination of fat cells to strengthen and define muscles. Barrymore is revealing that she incorporated the innovative technology into her wellness and fitness regimen to give her already healthy lifestyle an extra boost and take her workouts to the next level.

Barrymore is someone who admits that she always needs to put the "work" into her workouts. Her desired results don't just happen naturally, particularly in building up her core strength.

"After having my daughters my body changed and my core strength was turned upside down," Barrymore reveals. "EMSCULPT was ideal for me as it complemented my current routine which consists of a mix of dance cardio and Pilates to target my core muscles specifically. A little over a month post-treatment, I can visibly see the results and can tell a difference in my workouts – I feel that my core is much more engaged, improving my workouts and motivating me to push myself even further," added Barrymore.   

Barrymore is the ideal partner for EMSCULPT as she's known for her healthy lifestyle and commitment to wellness, in addition to empowering others to be their most confident selves. FDA-cleared for the strengthening and toning of abdominal muscles (along with the buttocks and most recently arms and legs), EMSCULPT supports a regimented fitness routine.  Utilizing patented HIFEM® magnetic field energy, it revolutionized the aesthetics industry with its launch last year. The unique technology induces approximately 20,000 supramaximal muscle contractions, which cannot be achieved voluntarily, to help target those hard-to-tone areas.

"We're thrilled to have Drew Barrymore on board as EMSCULPT's first celebrity ambassador," shared John Ferris, VP of US Marketing, of BTL, the company manufacturing the product. "Drew Barrymore embodies our mission of boosting patients' strength and confidence. Connecting her voice to our brand will help to further educate consumers and physicians about the benefits of EMSCULPT."

Through her partnership with EMSCULPT, Barrymore will share her treatment experience and results with media and on her social media channels. We encourage you to follow along in her journey online.

For more information on EMSCULPT, or to find a medical professional near you, please visit www.emsculpt.com.  

About BTL
Founded in 1993, BTL has grown to become one of the world's major manufacturers of medical and aesthetic equipment. With over 1,500 employees located in more than 53 countries, BTL has revolutionized the way to offer the most advanced non-invasive solutions for body shaping, skin tightening & other medical aesthetic treatments, including women's intimate health and wellness. BTL's brands include EMSELLA®, BTL Vanquish® ME, BTL Exilis® ULTRA, and BTL Cellutone®. Additional information can be found at www.bodybybtl.com.

BTL, leaders in non-invasive aesthetics, announced today that the week of May 20 has been officially proclaimed "National EMSCULPT Week." The revolutionary treatment transformed the aesthetics industry with its launch last year as the first and only non-invasive treatment to go beyond the elimination of fat cells to strengthen and define muscles. A recent survey found that 92% of NewBeauty readers claim feeling strong and powerful are the most important when it comes to body image. EMSCULPT addresses this sentiment by targeting muscles in tough to tone areas.

National EMSCULPT Week was just registered with the National Day Calendar organization, giving physician partners nationwide a campaign to further drive momentum around the innovative treatment. The program is ideally timed a week prior to the official kick off to summer. During this time, the brand will be providing practices with a variety of tools to promote timely trial and attract new patients. Keeping in mind that 88% of women are interested in a treatment that could help sculpt their body according to a NewBeauty study, National EMSCULPT Week provides the opportunity for consumers to get excited about something they've always wanted. In celebration of the official week, participating EMSCULPT practices will be hosting various promotions for EMSCULPT treatments and challenging patients to take their current fitness regimen to the next level via in-office events where patients can bring a friend to experience the benefits of EMSCULPT together.

"We're thrilled for EMSCULPT to be recognized with its very own week – we created a paradigm shift with this new non-invasive category; it is truly an honor as the National Day Calendar organization approves just 20 national holidays a year, and receives over 30,000 applications," said John Ferris, VP of US Marketing, of BTL, the company manufacturing the product. "This is a testament to the first-of-its-kind technology, and we're thrilled to provide our partners with an opportunity to grow their practice with EMSCULPT," added Ferris.

Utilizing HIFEM technology, EMSCULPT introduced an entirely new technology to aesthetics that goes beyond waistline reduction and elimination of fat cells to strengthen muscles. The unique technology induces approximately 20,000 supramaximal muscle contractions per 30 minute session and is the ONLY technology that strengthens and defines hard to target areas including the abdominals and buttocks, and most recently arms and legs with the introduction of the small applicator.

For more information on EMSCULPT or to find a medical professional near you, visit
www.emsculpt.com

About BTL
Founded in 1993, BTL has grown to become one of the world's major manufacturers of medical and aesthetic equipment. With over 1,500 employees located in more than 53 countries, BTL has revolutionized the way to offer the most advanced non-invasive solutions for body shaping, skin tightening & other medical aesthetic treatments, including women's intimate health and wellness. BTL's brands include EMSCULPT, BTL EMSELLA, BTL Vanquish ME, BTL Exilis ULTRA, and BTL Cellutone. Additional information can be found at www.bodybybtl.com.

BTL, leaders in non-invasive aesthetics, today announced that eight studies have been accepted for presentation at the 39^th Annual Conference of the American Society for Laser Medicine & Surgery (ASLMS) taking place March 27^th – 31^st.  Having transformed the body shaping category with its launch of EMSCULPT last year and with the acceptance of numerous studies for presentation during the elite conference, BTL further solidifies its position as a leader in aesthetic innovation.

Continuing the momentum of EMSCULPT, the brand will take its strengthening and toning capabilities to new areas of the body with the release of its small applicator. Up until now, there were only FDA cleared protocols for the abdominals and buttocks. With the addition of the small applicator, EMSCULPT is now cleared for strengthening, firming and toning of arms and thighs, further expanding the device’s versatility for physicians, adding additional revenue opportunities and patient’s satisfaction. Similar to abdominal and buttocks therapies, unique protocols have been developed for the treatment of the arms, thighs, and calves.

“We at BTL are always researching new innovations and raising the bar in aesthetics in order improve patient satisfaction and outcomes,” shared John Ferris, Vice President of US Marketing at BTL. “We’re looking forward to sharing our latest findings with the esteemed attendees of ASLMS and being the driving force behind the ongoing evolution of the category,” added John Ferris.

In addition to launching the small applicator, BTL will also highlight new clinical findings demonstrating long term EMSCULPT results with six-month and one-year data. Research will also be unveiled showcasing the impressive results for the new applications. Additionally, the brand will celebrate their physician supporters and the impact of EMSCULPT with an exclusive event Thursday evening. 

Brand presentations during the ASLMS conference will include:

Title: Ultrasonography Evaluation of Changes in Subcutaneous Abdominal Fat Thickness Following HIFEM Treatments: Results of 6-Month Follow-Up
Date: March 29^th
Time: 4:08 – 4:13 PM
Product: EMSCULPT
Presenter: Dr. Bruce E. Katz
Category: Clinical Applications - Multispecialty

Title: Body Contouring Device
Date: March 29^th
Time: 5:45 – 5:48 PM
Product: EMSCULPT
Presenter: Dr. Bruce E. Katz
Category: Tech Connect

Title: Combining Cryolipolysis and HIFEM to Optimize Body Contouring and Other Latest Developments
Date: March 30^th
Time: 7:16 – 7:28 AM
Product: EMSCULPT
Presenter: Dr. Suzanne Kilmer
Category: Full Spectrum of Body Contouring

Title: Non-Invasive Induction of Muscle Fiber Hypertrophy and Hyperplasia: Effects of High-Intensity Focused Electromagnetic (HIFEM) Field Evaluated in an In Vivo Porcine Model
Date: March 30^th
Time: 1:34 – 1:41 PM
Product: EMSCULPT
Presenter: Dr. Diane Duncan
Category: Basic Science and Transitional Research

Title: Biochemical Perspective of Fat Physiology After Application of HIFEM Field Technology: Additional Investigation of Fat Disruption Effects in A Porcine Study
Date: March 30^th
Time: 3:31 – 3:38 PM
Product: EMSCULPT
Presenter: Dr. Yael Halaas
Category: Basic Science and Transitional Research

Title: MRI Evaluation of Changes in Gluteal Muscles Following Treatments with the High-Intensity Focused Electromagnetic (HIFEM) Technology
Date: March 30^th
Time: 4:33 – 4:38 PM
Product: EMSCULPT
Presenter: Dr. Melanie D. Palm
Category: Clinical Applications - Cutaneous

Title: Long-Term Follow-Up on Patients with HIFEM-Induced Abdominal Tissue Changes: MRI and CT Assisted Quantification of Muscle Growth and Fat Reduction
Date: March 30^th
Time: 4:39 – 4:44 PM
Product: EMSCULPT
Presenter: Dr. David Kent
Category: Clinical Applications - Cutaneous

Title: Histological Examination of Skin Tissue in Porcine Animal Model After Simultaneous Application of Monopolar Radiofrequency and Targeted Pressure Energy
Date: March 31^st
Time: 8:25 – 8:32 AM
Product: BTL Aesthetics
Presenter: Dr. Brian Kinney
Category: Basic Science and Translational Research

The American Society for Laser Medicine and Surgery Inc. (ASLMS) has the ultimate responsibility for the planning, development and content of continuing education programs and presentations, including those highlighted above. BTL did not direct content or influence the planning or implementation of the ASLMS 39^th Annual Conference. The spontaneous opinions expressed by speakers and participants during these activities belong to those individuals. 

About EMSCULPT
Utilizing HIFEM techonolgy, EMSUCLPT introduced an entirely new techology to aesthetics that goes beyond waist line reduction and elimination of fat cells to strengthen muscles. The unique technology induces approximately 20,000 supramaximal muscle contractions per 30 minute session and is the ONLY technology that strengthens and defines hard to target areas including the abdominals and buttocks.

About BTL
Founded in 1993, BTL has grown to become one of the world’s major manufacturers of medical and aesthetic equipment. With over 1,500 employees located in more than 53 countries, BTL has revolutionized the way to offer the most advanced non-invasive solutions for body shaping, skin tightening & other medical aesthetic treatments, including women’s intimate health and wellness. BTL’s brands include EMSCULPT, BTL EMSELLA, BTL Vanquish ME, BTL Exilis ULTRA, and BTL Cellutone.

BTL, leader in non-invasive aesthetics, continues to take the aesthetics industry by storm. As the first to apply HIFEM® technology to aesthetics and women's health categories with the launch of EMSCULPT and BTL EMSELLA last year, the brand transformed treatment protocols within both categories. The industry buzz shows no signs of slowing down. The brand today announced two new accolades from NewBeauty and Harper's Bazaar magazines.

Both EMSCULPT and BTL EMSELLA received a NewBeauty Innovation Award, as featured in the Spring issue, on-stands today. The publication's "Innovation Award" is reserved only for the best-of-the-best products and technologies, deemed truly innovative by industry professionals and the editorial staff. Only eleven "Innovation" honors were awarded this year, with BTL earning two of the coveted spots on the list. Hailed as a treatment that captured the attention of both beauty enthusiasts and aesthetic professionals alike, EMSCULPT is touted for its impressive, dual results in clinical studies—having built muscle mass by 16% and decreased fat by 19% over the course of four sessions. BTL EMSELLA was recognized as the "kegel throne" and praised for its cutting-edge, completely non-invasive technology that promotes bladder control to help reduce, and even stop, urinary incontinence.

EMSCULPT was also named a 2019 Harper's Bazaar Anti-Aging Award Winner. The treatment earned the distinction of "Best Body Firming Treatment" within the "Best Pro Treatment" category as voted by the Harper's Bazaar editorial team, top dermatologists and influencers. EMSCULPT was showcased for its groundbreaking approach to body shaping—simultaneously addressing muscle and fat—to achieve more defined abdominals and lifted buttocks.  

"We're thrilled to receive these awards from such highly regarded publications. These outlets are always on the pulse of the latest technologies and responsible for shaping aesthetic trends so it's an honor for our innovation to be recognized by their editorial teams. This recognition further validates our authority within the space and impact our patented HIFEM technology has made," shared John Ferris, VP of Marketing at BTL.

Utilizing proprietary HIFEM® technology, protected by numerous US and foreign patents with more pending, EMSCULPT and BTL EMSELLA introduced an entirely new technology to non-invasive treatments.  Both treatmentstarget muscles to stimulate supramaximal muscle contractions, a contraction that cannot be achieved voluntarily, within the area of treatments. EMSCULPT, which strengthens and defines abdominal muscles and lifts the buttocks, is the first and only non-invasive treatment to go beyond elimination of fat cells. The treatment induces approximately20,000 supramaximal muscle contractions per 30 minute session. While BTL EMSELLA—a completely non-invasive solution for the treatment of all three forms of urinary incontinence with no downtime—treats the entire pelvic floor region at once to induce the equivalent of 11,000 kegels per session, all while the patient simply sits in a chair like device.

About EMSCULPT 
Utilizing HIFEM technology, EMSCULPT introduced an entirely new technology to aesthetics that goes beyond waist line reduction and elimination of fat cells to strengthen muscles as well. The unique technology induces approximately 20,000 supramaximal muscle contractions per 30 minute session and is the ONLY technology that strengthens and defines hard to target areas including the abdominals and buttocks.

About BTL EMSELLA 
BTL EMSELLA—the only treatment available to target a woman's entire pelvic floor region for the treatment of incontinence—is FDA cleared to treat all three types of urinary incontinence (stress, urge and mixed) in postpartum and postmenopausal women. Completely non-invasive, this unique technology is an innovation within the women's intimate health and wellness category. Harnessing the power of HIFEM technology it treats pelvic floor muscles at once via deep pelvic floor muscle stimulation to restore neuromuscular control—a single session provides 11,000 supramaximal pelvic floor muscle contractions, comparable to 11,000 Kegels. 

About BTL 
Founded in 1993, BTL has grown to become one of the world's major manufacturers of medical and aesthetic equipment. With over 1,500 employees located in more than 53 countries, BTL has revolutionized the way to offer the most advanced non-invasive solutions for body shaping, skin tightening & other medical aesthetic treatments, including women's intimate health and wellness. BTL's brands include EMSCULPT, BTL EMSELLA, BTL Vanquish ME, BTL Exilis ULTRA, and BTL Cellutone. 

SOURCE BTL Aesthetics

EMSCULPT®—the first and only non-invasive body shaping procedure to address both muscle and fat—revolutionized the aesthetics industry worldwide with its launch last year being recognized by top physicians as a gamechanger in body shaping. The treatment continues to gain recognition, this time by patients themselves. EMSCULPT was proclaimed one of the "Most Worth It" procedures of 2019 as recognized by RealSelf, the leading online resource to learn about cosmetic treatments and connect consumers with medical aesthetic doctors.

The RealSelf "Most Worth It" procedures are determined by patient's "Worth It" ratings–a proprietary consumer satisfaction score based on their first hand reviews following a treatment, and rate them as "Worth It" or "Not Worth It."  EMSCULPT received a "Worth It" rating of 92% in the newly released ranking, which is based on a cumulative "Worth It" rating over the past 12 months (Jan. 1 – Dec. 31, 2018).

"We're honored to receive this distinction, especially since it's coming from the patients who have invested in and experienced EMSCULPT themselves," shared John Ferris, VP of US Marketing, of BTL, the company manufacturing the product. "This is a testament to the treatment's innovative technology and impressive results. It also further demonstrates the impact the treatment has had on the industry since it just started rolling out in July."

Beyond consumers, the brand continues to receive rave reviews from physicians. Not only because of EMSCULPT's impact on the body shaping category overall, but also its ability to help grow a practice—physicians report that approximately 55% of EMSCULPT patients are new to the practice. The brand plans to further this industry buzz by showcasing EMSCULPT during the annual American Academy of Dermatology meeting this weekend (March 1^st – 3^rd). The brand will be hosting multiple peer-to-peer education sessions with leading physicians and clinical advisors. Sessions will showcase best practices and dramatic results achieved with EMSCULPT, as well as how the treatment can be leveraged as a key business driver. BTL will also show their appreciation for physician partners and their contributions to the success of EMSCULPT with an EMbassadors Party on Friday. 

Utilizing proprietary HIFEM® technology, protected by numerous US and foreign patents with more pending, EMSCULPT introduced an entirely new technology to aesthetics that goes beyond waist line reduction and elimination of fat cells to strengthen muscles as well. The unique technology induces approximately 20,000 supramaximal muscle contractions per 30 minute session and is the ONLY technology that destroys fat while simultaneously building muscle. The treatment is ideal for patients who live a healthy and active lifestyle but looking to strengthen and define hard to target areas including the abdominals and buttocks.

About BTL Industries
Founded in 1993, BTL has grown to become one of the world's major manufacturers of medical and aesthetic equipment. With over 1,500 employees located in more than 53 countries, BTL has revolutionized the way to offer the most advanced non-invasive solutions for body shaping, skin tightening & other medical aesthetic treatments, including women's intimate health and wellness. BTL Aesthetics' brands include EMSCULPT, BTL EMSELLA, BTL Vanquish ME, BTL Exilis ULTRA, and BTL Cellutone.  

About RealSelf Methodology 
RealSelf is the leading online marketplace for people to learn and share experiences about cosmetic procedures and connect with the right doctors. To be included in the 2019 Worth It Ranking, treatments must have received 20 or more "Worth It" or "Not Worth It" review ratings between Jan 1-Dec 31 2018 (reviews rated as "Not Sure" are excluded). To be recognized as a Most Worth It procedure in the surgical category, treatments must have received 100 or more "Worth It" or "Not Worth It" ratings between Jan. 1-Dec. 31 2018, while treatments in the nonsurgical category must have received a minimum of 30 eligible ratings. Ratings of "Not Sure" are excluded. To be recognized in either category, a procedure must have a cumulative Worth It Rating of 90% or higher.

Most notably, the brand will be introducing an entirely new category of technology and revolutionary body sculpting treatment via an invite-only event Thursday evening highlighting the use of HIFEM technology to address muscle and fat. The ASLMS event marks the first time the brand's new innovation and clinical efficacy of this particular energy source will be shared, making it one of this year's tent pole events of the conference. In total, seven abstracts have been submitted for the new technology, including 3 late breaking abstracts, and will be presented throughout the conference, all demonstrating the dramatic results of the first-of-its-kind treatment. "At BTL, we pride ourselves in being at the forefront of innovation and are honored to be unveiling our latest technology among our peers and top industry thought leaders at the renowned ASLMS conference," shared John Ferris, Vice President of US Marketing at BTL. "We're eager to share this industry-altering technology as we feel it further raises the bar in non-invasive body sculpting to ultimately transform the current treatment paradigm and be the driving force behind the ongoing evolution of the category," added Ferris.

The brand will also be highlighting its continued expansion within the Women's Health category with 3 additional abstracts. Two abstracts will highlight the brand's latest addition to its Pelvic Suite, BTL Emsella with HIFEM technology, for the strengthening the pelvic floor and its efficacy in treating urinary incontinence. The additional abstract will continue to demonstrate the superior results of the BTL Ultra Femme 360 device and its use of radiofrequency energy to improve vaginal laxity.

Body by BTL comes to life through a short video highlighting the treatment journey of eight individuals. Through these personal stories, it's apparent that these groundbreaking treatments deliver the dramatic results promised; to not only transform an individual's shape, but also their self-confidence. There is uniformity among the individuals that transposes their stories, further communicating their shared experience and empowering others. 

"BTL Aesthetics has long been regarded as a pioneer in body contouring. Through its ongoing innovation the brand continues to evolve, providing full body results and instilling confidence from the inside, out," shares John Ferris, VP of Marketing at BTL Aesthetics. "Physicians and patients alike continue to share the dramatic and empowering results our treatments yield. The Body by BTL campaign captures this sentiment and solidifies our unparalleled position within the aesthetics category."

BTL Aesthetics, leader in non-invasive aesthetic treatments, is excited to share the findings of a newly published study that boasts long lasting benefits of noninvasive, radiofrequency (RF) energy—as used in the breakthrough BTL Vanquish and Vanquish ME devices—to achieve abdominal circumferential reduction. Evaluating results four years post-treatment, this study is a first-of-its-kind for the non-invasive space as it goes beyond the standard evaluation time period, further demonstrating the technology's ability to help impart a permanent reduction of fat within the area of treatment. 

While a rapidly growing category, non-invasive body shaping treatments are still fairly new to the market, making physicians and consumers alike eager for more long-term data. Until now, there has been very little scientific evidence published to document how fat reduction achieved through noninvasive RF treatment evolves over time, making the release of this four-year data significant for both BTL Aesthetics and the industry at large. 

"We're thrilled to have this four-year follow-up data, as most clinical studies only incorporate evaluations 3-12 months following the procedure, and has remained the industry standard for post-treatment assessment." shares Tomas Boleslavsky of BTL Aesthetics. "The use of BTL Vanquish technology within this study further speaks to the brand's leadership within the industry, as well as its impressive and sustainable treatment results."

This study evaluated 13 individuals who received the BTL Vanquish treatment four years (+60 days) prior, utilizing the same measurement markers as those at the 1-month follow-up visit in the original Journal of Drugs and Dermatology study. The study findings prove that patients preserved an average 75.2% of the original body contouring effect four years post treatment series as demonstrated by abdominal circumferential reduction. While the treatments cannot prevent any future weight gains, the data is significant as it boasts sustained treatment results and no long-term side effects.

"This is a milestone study for the industry, as evidence of how the results evolve over longer periods of time hadn't been studied" shared Dr. Klaus Fritz. "While we [physicians] have always known the effects of radiofrequency induced apoptosis are permanent, this study's findings clinically demonstrate just that, along with the fact that long term results of BTL Vanquish treatments can be sustained."

About BTL Industries

Founded in 1993, BTL has grown to become one of the world's major manufacturers of medical and aesthetic equipment. With over 1,350 employees located in more than 53 countries, BTL has revolutionized the way to offer the most advanced non-invasive solutions for body shaping, skin tightening & other medical aesthetic treatments. BTL Aesthetics' brands include BTL Vanquish ME, BTL Exilis ULTRA, and BTL Cellutone. Additional information can be found at http://www.btlaesthetics.com.

Weight loss is always a top New Year's resolution. But for everyone who knows that fad diets, exercise regimens and expensive topical creams just don't work in terms of fat reduction and skin laxity, BTL Aesthetics is your 2017 solution. Recognized as a leader among industry peers and top aesthetics institutions, BTL Aesthetics— and the non-invasive devices it manufactures—received six awards in the U.S. and eight globally in 2016.

"We are thrilled that our next-generation, smartly-designed devices have received this kind of industry recognition," said John Ferris, U.S. Marketing Director for BTL Aesthetics. "It was a record year for the company in terms of awards, and anyone looking to trim, tone and tighten in the New Year should know that devices from BTL Aesthetics are highly regarded in the industry and among some of the country's top physicians."

2016 Awards for BTL Aesthetics

• Aesthetic Show: Best Non-Invasive Body Shaping Procedure, BTL Vanquish ME, BTL Exilis ULTRA and BTL Cellutone, Dr. Suneel Chilukuri
• Aesthetic Academy: Best Non-Invasive Body Shaping Procedure, BTL Vanquish ME, Dr. Jason Emer
• Aesthetic Everything: Top Shaping Company (No. 1); and a Top Ten Aesthetic Company
• My Face My Body:
  • U.S.: Best Skin Tightening Procedure, BTL Exilis ULTRA
  • Outside the U.S.: Best Body Reshaping Procedure with BTL Vanquish ME
• THE Aesthetic Guide: THE Aesthetic Industry Awards' Best New Combination Technology, BTL Exilis ULTRA
• Aesthetic and Anti-Aging Medicine European Congress (AMEC) 2016: Best Cosmetic Gynecology Device, BTL INTIMA

Breakthrough Devices—from Fat Reduction, to Tightening and Toning:  
BTL Vanquish ME is a breakthrough, physician-favored fat reduction treatment that is FDA-cleared for the circumferential reduction of the abdomen and thighs. The treatment was also recently shown, in a peer-review study published in the Journal of Drugs and Dermatology, that it treats more fat faster—and over a much larger area—than its competitors on the market, and without pain or bruising. BTL Vanquish and BTL Vanquish ME are the only radiofrequency devices on the US Aesthetic market that allow for non-contact, hands-free treatment of subcutaneous fat. Committed to innovation, the company's second-generation BTL Vanquish ME device was also recently proven—in a recent published clinical study—to provide more consistent outcomes and to reduce abdominal fat thickness by 53% more than its predecessor.

Additionally, BTL Aesthetics was also first-to-market with the technology in BTL Exilis ULTRA. This device is the first FDA cleared device that simultaneously transmits radio frequency and ultrasound energy. The combination of energies help optimize the patient's experience, as therapeutic temperature can be reached faster, more comfortably, and with better outcomes than either modality alone.

BTL Vanquish ME, BTL Exilis ULTRA and BTL Cellutone treatments are available through a network of licensed physicians and medically supervised spas. Visit www.btlaesthetics.us/find-a-physician/ to find a physician.

About BTL Industries  
Founded in 1993, BTL has grown to become one of the world's major manufacturers of medical and aesthetic equipment. With over 1,100 employees located in more than 53 countries, BTL has revolutionized the way to offer the most advanced non-invasive solutions for body shaping, skin tightening & other medical aesthetic treatments. BTL Aesthetics' brands include BTL Vanquish ME, BTL Exilis ULTRA, and BTL Cellutone. Additional information can be found at http://www.btlaesthetics.com.

About the Aesthetics Awards Referenced  
BTL Aesthetics won awards in 2016 from the following industry organizations: The Aesthetic Show, Aesthetic Academy, Aesthetic Everything, MyFaceMyBody, THE Aesthetic Guide, and the Aesthetic and Anti-Aging Medicine European Congress (AMEC).

BTL Aesthetics today announced the release of a clinical evaluation proving that its BTL Vanquish ME device was effectively redesigned for more efficient, predictable and homogenous energy delivery to the targeted tissue. The result: Significantly better outcomes in abdominal fat thickness reduction, 53% higher, with BTL Vanquish ME versus BTL Vanquish.

"We are committed to providing our physician network and their patients with the most highly-advanced devices on the market," said Tomas Boleslavsky, Director of Clinical at BTL Aesthetics. "These clinical results, showing that our smartly-designed, next-generation device outperformed its predecessor, really speak to BTL Aesthetics' innovative approach and entrepreneurial spirit."

Background:

BTL Vanquish launched in 2013, was a breakthrough device for noninvasive fat reduction. Not stopping there, BTL Aesthetics' commitment to an innovative approach quickly resulted in the development of BTL Vanquish ME (Maximum Energy), which debuted in 2015. BTL Vanquish ME is a physician-favored fat reduction treatment that is FDA-cleared for the circumferential reduction of the abdomen and thighs. The treatment was also recently shown, in a peer-review study published in the Journal of Drugs and Dermatology, that it treats more fat faster—and over a much larger area—than its competitors on the market. BTL Vanquish and BTL Vanquish ME are the only radiofrequency devices on the US Aesthetic market that allow for non-contact, hands-free treatment of subcutaneous fat.

About the Clinical Study:

The multi-center study, conducted by Drs. Nicole Hayre, Peter Jenkin and Melanie Palm, sought to compare clinical outcomes of a noninvasive selective radiofrequency (RF) field device (BTL Vanquish ME) with its predecessor (BTL Vanquish). A total of 36 subjects with BMIs under 30 but above 24, were randomly assigned to be treated in Group A (BTL Vanquish ME) or Group B (Vanquish) to obtain a side-by-side comparison of the devices' efficacies. Each subject received four, once-weekly, 45-minute treatments with their group's determined device. Measurements of subjects' abdominal fat were taken prior to the first treatment and again four weeks after finishing the final treatment. Subjects had also been instructed to maintain their usual diet and lifestyle throughout the duration of the study.

Results

Abdominal fat layer thickness reduction at 30 days post treatment was the primary outcome measurement in the study as measured by ultrasound. The degree in fat layer thickness between Group A and B was statistically significant (p<0.008), and data showed that fat for Group A (BTL Vanquish ME) and Group B (BTL Vanquish) was reduced by 29.5% and 15.2%, respectively. That represents a 53% higher reduction of abdominal fat layer thickness with Group A than for those in Group B. Every subject in the study showed a reduction in the abdominal fat layer thickness.

-       Group A: Reduction ranged from 2.0 to 6.6 mm (average of 4.17 ±1.42 mm)
-       Group B: Reduction ranged from .07 to 10.4 mm (average of 2.72 ± 2.21 mm)

The standard deviation of ultrasound measurements in Groups A and B were 1.42 mm and 2.21 mm, respectively—and this reduction in standard deviation of fat reduction measurements in Group A vs Group B is evidence that the BTL Vanquish ME™ provides more consistent performance.

Finally, using the measured reduction in fat layer thickness and the treatment surface area of the applicator (2100 cm²or 325.5 square inches), a reduction of 0.876 liter (0.23 liquid gallon) and 0.571 liter (0.15 liquid gallon) of fat were calculated for Groups A and B, respectively.  (Volume lost = fat layer thickness reduction x effective area or spot size of the applicator (2100 cm2; 325.5 square inches).  This assumes an homogenous response to treatment.

Further speaking to its uniqueness in the market, the BTL Vanquish ME device holds three patents: One, granted in 2013, protects the non-contact method of adipose tissue treatment. The second, issued in September 2016, is for the feedback power control device for non-invasive treatment of skin and human tissue. The third—issued in October—refers to a new method for treating subcutaneous tissue that positions one or more applicators adjacent to the skin of a patient, but not touching the skin or in need of continual movement by the applicator. These applicators, which transmit electromagnetic energy into the skin where it can be used for subcutaneous tissue treatment, may also be used for tightening the skin and for remodeling collagen tissue in the subcutaneous tissue. Additionally, airflow can be provided between the applicator and the skin by positioning an air mover (attached or made part of the applicator) close to the skin.

BTL Vanquish ME treatments are available through a network of licensed physicians and medically supervised spas. Visit www.btlvanquishme.com to find a physician for treatment.

About BTL Industries

Founded in 1993, BTL has grown to become one of the world's major manufacturers of medical and aesthetic equipment. With over 1,100 employees located in more than 53 countries, BTL has revolutionized the way to offer the most advanced non-invasive solutions for body shaping, skin tightening & other medical aesthetic treatments. BTL Aesthetics' brands include BTL Vanquish ME, BTL Exilis Ultra, and BTL Cellutone.

BTL Aesthetics today announced the release of a peer review study, published in the Journal of Drugs in Dermatology (JDD), addressing effectiveness and patient satisfaction of three "hands-free" noninvasive body contouring devices: cryolipolysis, 1060nm diode laser, and BTL Vanquish ME. The study, written by Drs. Suneel Chilukuri and Gregory Meuller, analyzed peer reviewed studies on the three devices and their mechanism of action, as well as on their evidence of safety and efficacy.

Based on the facts presented, BTL Vanquish ME was proven to be more cost effective and to remove fat faster—three to five times more speed coverage, per treatment regimen—over a higher coverage area.

BTL Aesthetics today announced that it has received a new designation from the Food &
Drug Administration (FDA) for its award-winning, non-invasive fat reduction treatment, BTL Vanquish ME. The physician-favored treatment is now FDA-cleared for the circumferential reduction of the abdomen and thighs. The clearance was secured following several rounds of clinical testing to provide ample evidence of its efficacy and safety—which has also been previously documented thanks to two studies published in peer-reviewed journals.   

"We're excited to receive our latest FDA clearance, as it further demonstrates the versatility of the BTL Vanquish ME system and its efficacy," said Tomas Boleslavsky, Director of Clinical at BTL Aesthetics. "This clearance, which was secured in part thanks to extensive clinical research, is truly a further testament to BTL Vanquish ME's superior and consistent results."

Harnessing the power of high-frequency, Selective RF energy, BTL Vanquish ME induces death of fat cells through apoptosis, and the body flushes fat cells out of the body naturally to help slim the abs, belly, love handles, and now thighs. Boasting the largest spot size in the industry, the unique contactless panel allows patients to treat a broad area at once, resulting in more even results with no lines of demarcation. Similarly to treatment of the abdomen, which covers the core from flank-to-flank, the Flex Applicator—specially designed to treat and adjust to the thighs—simultaneously slims both the inner/outer thighs and saddle bags. This allows for enhanced patient outcomes, shorter treatment times and elimination of additional consumable costs for the physician—a sharp contrast to similar systems which focus solely on smaller areas or specific fat deposits, making BTL Vanquish ME a more affordable treatment option.

"The upper legs continue to be a common area of complaint for my patient base, with many inquiring about procedures to help slim, shape, and tone thighs," says Dr. Annie Chiu, Board Certified Dermatologist and founder of The Derm Institute in Redondo Beach, CA. "With the BTL Vanquish ME Flex Applicator at my practice, we have been able to treat both the inner and outer thigh in each session at the same time, giving patients a circumferential reduction in their thighs and a slimmer leg appearance," added Chiu.

This newest distinction further supports previous studies published in peer-reviewed journals including Dermatologic Therapy and the Journal of Drugs and Dermatology both of which highlight the effectiveness of BTL Aesthetics' patented radio frequency technology to reduce the circumference of thighs. In clinical studies, over 80% of subjects experienced a statistically high and significant circumferential reduction with four, 30-minute treatment sessions per leg, delivered once a week over a four week period. BTL Vanquish ME treatments are available through a network of licensed physicians and medically supervised spas. Visit btlaesthetics.com to find a physician for treatment.

About BTL Industries

Founded in 1993, BTL Industries is a privately owned developer and manufacturer of medical and aesthetic equipment. BTL currently has over 1,050 employees and direct offices in more than 53 countries. BTL Aesthetics, a division of BTL, has revolutionized the way to non-invasively remove adipose tissue; it currently ranks 2nd among the non-invasive body shaping and tightening manufacturers globally. BTL Aesthetics' brands include BTL Vanquish ME, BTL Exilis Ultra, and BTL Cellutone.

The noninvasive Flex applicator eliminates unwanted fat by delivering RF thermal energy to the target body area without touching the skin. By hovering over the upper legs, the device selectively destroys fat cells in deep tissue to redefine thighs and saddlebags. With four weekly treatments, patients can expect to enjoy tighter, thinner thighs.

Comfortable, safe, and noninvasive solution – no anesthesia, pain medication or downtime is required for treatment. Short 30-minute sessions - generally scheduled one week apart over four to six weeks. Affordable and convenient – return immediately to routine activities. Find your nearest BTL Vanquish ME™ operator at Find a Physician - http://www.btlaesthetics.us/find-a-physician

BTL Aesthetics, the manufacturers of BTL Vanquish ME – an award-winning, non-invasive fat reduction treatment – today announced the introduction of three new products that take body shaping and skin toning to the next level.

"As a leader in aesthetics innovation, we're always looking for new ways to help our physician partners achieve optimal results," said Jan Zarsky, Director of North America for BTL Aesthetics. "The addition of BTL Exilis ULTRA – the only system with simultaneous delivery of radio frequency and ultrasound - helps raise the bar in combination therapy. BTL Cellutone, when used in conjunction with BTL Vanquish ME, delivers what physicians are referring to as the "shock and awe" affect, as the two-part treatment is helping to enhance patient's experience, while achieving consistent and fast results," added Zarsky.

BTL Exilis ULTRA

Taking the company's widely used body shaping and skin rejuvenating treatment, Exilis, to the next level; BTL Exilis ULTRA is the first non-invasive aesthetic device to simultaneously deliver ultrasound and radio frequency energy. The combination of energies help to optimize the patient's experience, as therapeutic temperature can be reached faster than either modality alone. Additionally the design of the applicator is unique in the fact it has a cooling tip to allow physicians to adjust the level of penetration for enhanced results, as well as make the treatment extremely versatile.

"I've been very impressed by BTL Exilis ULTRA as it allows me to utilize these dual modalities (radio frequency and ultrasound) in new ways," said Dr. Suneel Chilukuri, Cosmetic and Dermatologic Surgeon in Houston, TX. "In addition to seeing great results on the arms and neck, which are challenging areas to treat, I'm also utilizing it to rejuvenate lips. In fact, patients have seen such positive results, that they're looking to come in sooner to have additional areas treated." added Chilukuri.

BTL Cellutone

Utilizing targeted vibrations, BTL Cellutone can be used as a stand-alone device or in combination with other aesthetic therapies such as non-invasive fat reduction and tightening treatments. BTL Vanquish ME utilizes selective radio frequency energy to heat and ultimately destroy fat cells which are then removed from the body naturally. When paired with BTL Cellutone, the patients experience is significantly improved thanks to its oscillating massage therapy, as it helps increase blood supply, resulting in better lymphatic drainage and improved elimination of fat cells.

"My practice has been using BTL Cellutone in conjunction with BTL Vanquish ME for treatment of both the abdomen and thighs. The combination therapy has helped improve skin texture and tightening, as well as deliver faster circumferential reduction, so much so that I am seeing results as early as 3 sessions compared to what I used to see weeks after four treatments," said Board Certified Cosmetic and General Dermatologist, Annie Chiu, based in Redondo Beach, CA. "The treatment is also well tolerated with patients, and the addition of Cellutone appeals to these same patients with the improved skin appearance," added Chiu.

BTL Exilite

Tapping into the resurfacing ability of IPL (Intense Pulse Light), BTL expands its treatment and combination therapy portfolio with the launch of a customizable IPL device. BTL Exilite will help physicians address vascular and pigmented lesions, hair removal and acne. When combined with radio frequency in the BTL Exilis treatment, it will allow for targeted tightening, plus resurfacing, which is an ideal complement to the "liquid facelifts" being performed in office.

"I have found the new BTL Exilite to be an easy transition from our other pulsed light systems. Treatments are fast, well tolerated and effective," said Jeffrey Hunt, D.O., R.V.S., R.V.P.I., out of Tampa Bay, FL. "BTL Aesthetics has put together a winning combination of features in their new IPL. The system offers plenty of power, custom treatment parameter settings and speed to perform effective IPL treatments," added Hunt.

BTL Cellutone, BTL Exilis ULTRA, BTL Exilite and BTL Vanquish ME treatments are available through a network of licensed physicians and medically supervised spas. Visit btlaesthetics.com to find a physician for treatment.

About BTL Industries

Founded in 1993, BTL Industries is a privately owned developer and manufacturer of medical and aesthetic equipment. BTL currently has over 1,050 employees and direct offices in more than 53 countries.

BTL Aesthetics, a division of BTL, has revolutionized the way to non-invasively remove adipose tissue; it currently ranks 2nd among the non-invasive body shaping and tightening manufacturers globally. BTL Aesthetics' brands include BTL Exilis Elite, BTL Vanquish ME, and BTL Exilite.

BTL Aesthetics today announced the release of a new study which further demonstrates the superior results of body shaping leader, BTL Vanquish, a radio frequency treatment that offers patients a solution to reducing stubborn fat around the midsection and effectively improves contouring of the abdomen and love handles. The study, conducted by board certified plastic surgeon, Amir Morandi, MD and board certified dermatologist, Melanie Palm, MD, aimed to determine the efficacy and safety of the popular protocol.

The study found that subjects experienced an average of 1.7 inch reduction in abdominal circumference following a controlled series of treatments with BTL Vanquish. This reduction was specifically noteworthy as the results were similar to a previous study conducted of 40 participants with an overall higher BMI on average, demonstrating that the treatment is beneficial for a variety of body types, including those with lower BMI levels. Additionally, in order for the study to be considered effective, the physicians were also looking for a statistically significant reduction in circumference three months following treatment in order to show the permanent destruction of fat cells, which was concluded as effective for the subjects in this study.

"As a practicing cosmetic dermatologist, seeing a significant reduction in subjects with a lower BMI was particularly impressive to me as it shows how BTL Vanquish is also a reliable option for more active patients, especially those who need that little extra boost to remove lingering or stubborn fat to further support a healthy lifestyle," said Dr. Palm. "The results also show the continued advancements in radio frequency technology, as I personally see radio frequency as the next big wave in cosmetic dermatology," added Dr. Palm.

The study was conducted on 24 subjects, primarily female, ranging from 30-69 in age, who all received four weekly 45-minute radio frequency treatments targeting the abdomen area and love handles. Results were tracked through standardized digital photographs and circumference measurements, and compared to biometric measurements such as weight, hydration and body fat collected at baseline and each study visit. In addition, 4 subjects were randomly selected for serum lipid and liver-related blood tests at baseline and periodically throughout treatment and follow up visits to determine safety.

"As a company committed to innovation, we're excited by the impressive results we're continuing to see through additional testing of our Vanquish device," said Jan Zarsky, Director of North America of BTL Aesthetics. "With the continued support of our valued physician partners, and recent introduction of the next generation, BTL Vanquish ME, we're confident that we'll continue to impress patients with safe and visible results," added Zarsky.

BTL Vanquish and Vanquish ME utilize patented, non-invasive and painless radiofrequency technology to reduce fat in the core and abdomen. Featuring the industry's largest treatment spot size, the newly released BTL Vanquish ME is designed to treat the whole abdomen from flank to flank during one session for faster, smoother results. BTL Vanquish ME is clinically shown to be an efficacious and repeatable procedure for those looking to eliminate belly fat and love handles without surgery.

BTL Vanquish is the World’s Only Operator-Independent Radio Frequency Device to Reduce Circumference of the Waistline

BTL Industries, a leading manufacturer of devices for medical and aesthetic use, announced the FDA clearance of its groundbreaking BTL Vanquish device for circumferential reduction of the abdomen area. The system’s patented technology creates a high-frequency energy field that targets the thermal effects into the fat layer while protecting surrounding skin tissue. Further, BTL Vanquish provides optimal aesthetic results across the entire abdominal area with maximum safety and comfort without surgery or downtime.

“FDA clearance of Vanquish is a significant step forward in providing the newest treatment option for body slimming and shaping.”

“BTL Vanquish is truly a breakthrough technology. Published clinical studies show it permanently destroys unwanted fat for safe and measurable circumferential reduction of the abdominal area without the cost and inconvenience of surgery,” says David McDaniel, MD, a leading dermatologist and investigator of high-tech devices for non-invasive body contouring. “FDA clearance of Vanquish is a significant step forward in providing the newest treatment option for body slimming and shaping.”

BTL Vanquish is radically different from other systems that use a point source of heat or cold. Instead, BTL Vanquish uses a panel array that emits selective RF energy with the largest spot size in the industry to treat the entire core in one application. Providing a clinically proven and safe treatment option without touching the patient’s skin, the breakthrough technology of BTL Vanquish surpasses earlier treatment options that require uncomfortable suction or labor-intensive application. The BTL Vanquish achieves results that all patients want -- a beautifully contoured abdomen and smaller waistline.

“FDA clearance of BTL Vanquish marks a defining moment in our journey to provide physicians and their patients an elegant treatment option to target fat cells and bring about a reduction in the waist circumference,” said Andrea Morrison, BTL’s Director of Clinical Development. “BTL is proud to offer patients a comfortable, affordable and noninvasive body shaping experience. This regulatory milestone underscores BTL’s commitment to deliver meaningful solutions to aesthetic patient care.”